Stock Price Quote

IND-SWIFT LTD.

NSE : INDSWFTLTDBSE : 524652ISIN CODE : INE788B01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE25.36-1.33 (-4.98 %)
PREV CLOSE ( ) 26.69
OPEN PRICE ( ) 26.40
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 28067
TODAY'S LOW / HIGH ( )25.36 27.88
52 WK LOW / HIGH ( )15.19 34.49
NSE25.59-1.35 (-5.01 %)
PREV CLOSE( ) 26.94
OPEN PRICE ( ) 27.89
BID PRICE (QTY) 25.59 (138)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 61109
TODAY'S LOW / HIGH( ) 25.59 27.89
52 WK LOW / HIGH ( )14.3 34.7
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 06-06 1986
Management Info
S R Mehta - Chairman Gopal Munjal - Managing Director
Registered Office

Address 781,Phase 2,Industrial Area,
Chandigarh,
Union Territory-160002

Phone 0172-2638781 / 786

Email companysec@indswift.com

Website www.indswiftltd.com

Registrars Details
Alankit Assignments Ltd.
Alankit House , 4 E/2,Jhandewala Extension,,New Delhi
Listing : BSE, NSE

NEWS

04Jan IND-Swift informs about scheme of arra
With reference to earlier disclosure dated 18th May, 2024 regarding the..
09Dec Clarification sought from Ind-Swift Ltd
The Exchange has sought clarification from Ind-Swift Ltd on December 9,..
28Sep IND Swift informs about closure of tra
IND Swift has informed that as per the Company’s Code of Conduct for pre..
29Aug Ind-Swift informs about newspaper publ
Pursuant to the provisions of SEBI (Listing Obligations and Disclosure R..
02May Ind-Swift submits board meeting intima
Pursuant to the provisions of Regulation 29(1)(a) of the Securities &..

Financials

in Millions
QTR Sep 24 ANNUAL 24
Net Profit41.1099999999999142.33
Gross Profit 41.1099999999999 164.65
Operating Profit 190.321065.08
Net Sales 1363.455022.48

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE)
peergroup  13417.20 (0.96%)
M.Cap ( in Cr)17214.12
Procter&Gamble Healt (BSE)
peergroup  5424.60 (2.04%)
M.Cap ( in Cr)9004.50
Ajanta Pharma (BSE)
peergroup  2879.50 (2.30%)
M.Cap ( in Cr)35968.44
Alivus Life Sciences (BSE)
peergroup  1062.45 (4.08%)
M.Cap ( in Cr)13018.50
Medplus Health Servi (BSE)
peergroup  797.25 (2.81%)
M.Cap ( in Cr)9542.59

Shareholding Pattern

PROMOTERS 55.58%
NON-INSTITUTION 44.42%
FI/BANKS/INSURANCE 0%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Ind-Swift Ltd.

Ind-Swift Ltd. was incorporated in the year 1986. Its today's share price is 25.36. Its current market capitalisation stands at Rs 137.36 Cr. In the latest quarter, company has reported Gross Sales of Rs. 5287.13 Cr and Total Income of Rs.5602.41 Cr. The company's management includes Puneet Khurana, Prabhat Khurana, Subodh Gupta, Bhupinder Singh, Jagvir Singh Ahluwalia, Anoop Michra, Subhash Chander Galhotra, Rishav Mehta, Himanshu jain, N R Munjal, V R Mehta, Gopal Munjal, S R Mehta.

It is listed on the BSE with a BSE Code of 524652 , NSE with an NSE Symbol of INDSWFTLTD and ISIN of INE788B01028. It's Registered office is at 781,Phase 2,Industrial AreaChandigarh-160002, Union Territory. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Jain & Associates, JK Jain & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.